EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

CCNE1 : A Cell Cycle Regulator That Influences Tumor Progression

Liang Yan, Siyi Liu iD, Yanling Li, Qian He, Chen Long iD, Ning Tang, Yanhong Zhou iD

Cancer Medicine · 2026

DOI: 10.1002/cam4.72336 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2026. Verfasst von Liang Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Office of Scientific Research Administration, the Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hosp…. Hauptthemen laut MEDLINE: Cyclin E, Oncogene Proteins, Neoplasms, Cell Cycle. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hunan Provincial Natural Science Foundation, Health Commission of Hunan Province Research Project, National Natural Sciences Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclin E1 (CCNE1), a pivotal member of the cyclin family, governs the G1/S phase transition of the cell cycle by binding to and activating cyclin‐dependent kinase 2 (CDK2), thereby initiating DNA replication and driving S‐phase entry. In a broad spectrum of human malignancies—including breast, ovarian, gastric, and non‐small cell lung cancers—amplification or overexpression of CCNE1 disrupts the orderly regulation of cell cycle progression, leading to uncontrolled proliferation, impaired DNA damage repair, and genomic instability. These oncogenic consequences are intimately associated with increased tumor aggressiveness, poor patient prognosis, and diminished therapeutic efficacy. This review provides an integrated examination of CCNE1 biology, spanning its physiological regulation in the cell cycle, the molecular mechanisms by which its dysregulation drives tumorigenesis and drug resistance, the clinical implications of CCNE1 amplification as both a prognostic biomarker and a predictor of therapeutic response, and the emerging strategies to target CCNE1‐driven vulnerabilities. By synthesizing findings across diverse cancer types and regulatory layers, we evaluate the translational potential of CCNE1 as a diagnostic marker and therapeutic target, and highlight key challenges and opportunities for future investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin EOncogene ProteinsNeoplasmsCell CycleHumansDisease ProgressionAnimalsGene Expression Regulation, NeoplasticGene AmplificationGenomic InstabilityBiomarkers, Tumor

Stichwörter der Autor:innen

CCNE1cell cycle regulationgene amplificationgenomic instabilitytumor progression

Substanzen

Cyclin ECCNE1 protein, humanOncogene ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Office of Scientific Research Administration, the Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
  • Cancer Research Institute, Basic School of Medicine, Central South University, Changsha, Hunan, China.
  • Department of Nuclear Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
  • Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
  • Department of General Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.

ORCID-Profile: Siyi Liu, Chen Long, Yanhong Zhou

Förderung

  • Hunan Provincial Natural Science Foundation
  • Health Commission of Hunan Province Research Project
  • National Natural Sciences Foundation of China
  • Hunan Cancer Hospital Climb Plan
  • High-Level Talent Support Program of Hunan Cancer Hospital
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Yan, L., Liu, S., Li, Y., He, Q., Long, C., Tang, N., & Zhou, Y. (2026). CCNE1 : A Cell Cycle Regulator That Influences Tumor Progression. Cancer Medicine. https://doi.org/10.1002/cam4.72336

Vancouver

Yan L, Liu S, Li Y, He Q, Long C, Tang N, et al. CCNE1 : A Cell Cycle Regulator That Influences Tumor Progression. Cancer Medicine. 2026. doi:10.1002/cam4.72336

BibTeX
@article{Yan2026,
  author = {Yan, Liang and Liu, Siyi and Li, Yanling and He, Qian and Long, Chen and Tang, Ning and Zhou, Yanhong},
  title = {CCNE1 : A Cell Cycle Regulator That Influences Tumor Progression},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72336}
}
Kostenlos starten →